Počet záznamov: 1
betametazón
SYS d001623 LBL 00000nz--a2200000o--4500 005 20250606214349.8 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D04.210.500.745.432.769.199 065 $a D04.210.500.908.093 066 $a 01 $c 03 150 $a betametazón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Betadexamethasone $2 eng 450 $w v $a Flubenisolone $2 eng 450 $w v $a betadexametazón $2 slo 450 $w v $a flubenizolon $2 slo 550 $7 sllk_us_auth*d000893 $Y Anti-Inflammatory Agents $w P $a antiflogistiká 550 $7 sllk_us_auth*d005938 $Y Glucocorticoids $w P $a glukokortikoidy 550 $7 sllk_us_auth*d018927 $Y Anti-Asthmatic Agents $w P $a antiastmatiká 665 $a 64(63) $2 eng 680 9-
$i A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) $2 eng 750 -2
$a Betamethasone $2 eng 980 $x M
Počet záznamov: 1